Volume 9 (2022)

Molecular selection of therapy in metastatic colorectal cancer: the FOCUS4 molecularly stratified RCT

• Journal:
  Efficacy and Mechanism Evaluation Volume: 9, Issue: 9
• Published:
  21 December 2022

Leucine and perindopril to improve physical performance in people over 70 years with sarcopenia: the LACE factorial RCT

• Journal:
  Efficacy and Mechanism Evaluation Volume: 9, Issue: 8
• Published:
  30 August 2022

Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients:the R4-RA RCT

• Journal:
  Efficacy and Mechanism Evaluation Volume: 9, Issue: 7
• Published:
  22 August 2022

OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16-25 years: a RCT

• Journal:
  Efficacy and Mechanism Evaluation Volume: 9, Issue: 6
• Published:
  5 July 2022

Omalizumab for severe atopic dermatitis in 4- to 19-year-olds: the ADAPT RCT

• Journal:
  Efficacy and Mechanism Evaluation Volume: 9, Issue: 5
• Published:
  6 June 2022

Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT

• Journal:
  Efficacy and Mechanism Evaluation Volume: 9, Issue: 4
• Published:
  6 June 2022

An adapted social communication intervention at home and education to promote social communication change in children with severe autism: the PACT-G RCT

• Journal:
  Efficacy and Mechanism Evaluation Volume: 9, Issue: 3
• Published:
  17 May 2022

The interleukin 1 receptor antagonist anakinra to reduce disease severity of palmoplantar pustulosis in adults: APRICOT RCT and PLUM mechanistic study

• Journal:
  Efficacy and Mechanism Evaluation Volume: 9, Issue: 2
• Published:
  30 March 2022

Monoclonal antibody BTT1023 targeting vascular adhesion protein 1 for treating primary sclerosing cholangitis: BUTEO single-arm Phase II trial

• Journal:
  Efficacy and Mechanism Evaluation Volume: 9, Issue: 1
• Published:
  10 March 2022